We then found that RNA extracted from two whole tumor sections whose CAFs were deemed negative for the type one interferon response via microarray and Q-RT-PCR analyses, showed considerably lower levels of both IFN-β and OAS2 as compared to whole tumors from two patients from whom activated interferon response CAFs were obtained (Figure 1D). The gene discussed is OAS2; the disease is neoplasm.